Drugs / Gonadotropin-releasing hormone (GnRH)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00796289 | Feb → Dec 2009 | infertility disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01381016 | Jun 2011 → Jan 2013 | infertility disorder, obesity disorder | University of Colorado, Denver | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT02431416 Comparator | May 2015 → Dec 2017 | central precocious puberty | Region Örebro County | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gonadotropin-releasing hormone (GnRH) | “Gonadotropin-releasing hormone (GnRH)” NCT00796289 ↗ |
| Route | Intravenous | “Gonadotropin releasing hormone GnRH (Relefact LHRH) iv injection” NCT02431416 ↗ |